Latest news
ADHD: First New Drug Class in Decades Gets FDA Approval - DenkstromDenkstrom · Sat, 08 Aug 2026 00:15:45 GMTWill Newly Approved Centanafadine Transform ADHD Care? - Physician's WeeklyPhysician's Weekly · Fri, 07 Aug 2026 14:40:03 GMTThe Difference the New ADHD Drug Named Simtriyo Makes and How It Works in the Brain - inklinkl · Fri, 07 Aug 2026 07:00:00 GMTCentanafadine Gains FDA Approval for ADHD Across Age Groups - Patient Care OnlinePatient Care Online · Wed, 05 Aug 2026 15:24:22 GMTCentanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD - Psychiatric TimesPsychiatric Times · Mon, 03 Aug 2026 18:23:02 GMTSymptoms improved within first week: FDA approves new ADHD drug for children, adults - YnetnewsYnetnews · Sun, 02 Aug 2026 16:49:44 GMTA New Mechanism for ADHD: Raman Baweja, MD, on Centanafadine's FDA Approval - Psychiatric TimesPsychiatric Times · Fri, 31 Jul 2026 16:39:39 GMTFDA approval of Simtriyo gives ADHD prescribers a new option—and new safety questions - MDLinxMDLinx · Thu, 30 Jul 2026 13:58:55 GMT